US Patent 7740868 Activatable clostridial toxins
Patent 7740868 was granted and assigned to Allergan, Inc. on June, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+240 characters)
Article
Patent abstract
Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Ester Fernandez-Salas0
J. Oliver Dolly0
Joseph Francis0
Kei Roger Aoki0
Lance E. Steward0
Marcella A. Gilmore0
Sanjiv Ghanshani0
Shengwen Li0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07740868 Activatable clostridial toxins US Patent 7740868 Activatable clostridial toxins
Infobox
Patent Number
077408680
Patent Number
77408680
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077408680
Date of Patent
June 22, 2010
0Patent Application Number
118321730
Date Filed
August 1, 2007
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07740868 Activatable clostridial toxins
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07740868
Date of patent
June 22, 2010
Patent application number
11832173
Date Filed
August 1, 2007
Patent primary examiner
Find more entities like US Patent 7740868 Activatable clostridial toxins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
